{2-[(4-methyl-1-piperidinyl)methyl]phenyl}methanol hydrochloride, 95.0%, 1g

3-(1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)propiolic acid, 98%, 100mg

CLINAFLOXACIN, 95%, 250mg

EDTA-Manganese disodium salt x 2H2O, min. 93%, for synthesis, 250 g, plastic packaging.

3-BROMO-5-CHLORO-4-HYDROXYBENZOIC ACID, 95%, 100mg

2,5-Thiophenedicarboxylic acid, 97.0%, 1g

Ethyl 5-chloro-3-methylisoxazole-4-carboxylate, 95.0%, 5g

Methyl 2-chloro-4-formylbenzoate, 95.0%, 1g

Methyl 3-Amino-2-methylbenzoate>98.0%(GC)(T)5g

Met-Gly, 95.0%, 5g

(R)-5-(HYDROXYMETHYL)-4-METHYLMORPHOLIN-3-ONE, 95.0%, 250mg

N-(4-Methylphenyl)Sulfonylacetamide, 97%, 10g

(2-aminocyclohexyl)methanol hydrochloride, 95.0%, 1g